Argan Inc (AGX)
Official siteINDUSTRIALS • ENGINEERING & CONSTRUCTION • NYSE
Market Cap: $4.30B
Last updated: Nov 17, 2026 at 11:04 AM ET
Argan Inc (AGX) Stock Forecast
Analysts expect Argan (AGX) to earn $13.27 per share in the fiscal year ending Jan 31, 2027, on revenue of $1.40B. Of 5 analysts, 2 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Jan 31, 2027 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.40, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 40% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 1 | 20.0% |
| Hold | 3 | 60.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 21.4% and revenue estimates rise 20.7%.
- Fiscal year ending Jan 31, 2027
- $13.27
- EPS consensus, revenue $1.40B
- Fiscal year ending Jan 31, 2028
- $16.11
- EPS consensus, revenue $1.69B
- Next report
- Dec 9, 2026
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jan 31, 2027 | $13.27 | $12.51 to $14.33 | 5 | $1.40B | $1.35B to $1.47B | 6 |
| Jan 31, 2028 | $16.11 | $12.66 to $19.07 | 5 | $1.69B | $1.50B to $1.85B | 6 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jan 31, 2027 | $3.20 | $2.77 to $4.01 | 7 | $375.10M | $333.20M to $426.30M | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 5 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jan 31, 2027 | 3 | 1 |
| Fiscal year ending Jan 31, 2028 | 2 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Jan 31, 2027 has risen 8.4% from $12.24.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jan 31, 2027 | $13.27 | $13.06 | $12.09 | $12.24 | $12.24 | +8.4% |
| Fiscal year ending Jan 31, 2028 | $16.11 | $16.23 | $15.99 | $16.25 | $16.25 | -0.9% |
Frequently Asked Questions About AGX
What is the AGX stock forecast?
Consensus analyst estimates put Argan's EPS at $13.27 for the fiscal year ending Jan 31, 2027, on revenue of $1.40B. The consensus rating from 5 analysts is Buy.
How do analysts rate AGX stock?
Of 5 analysts covering Argan, 1 rates it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from AGX next year?
For the fiscal year ending Jan 31, 2027, the consensus EPS estimate is $13.27, with estimates from $12.51 to $14.33 from 5 analysts. For the fiscal year ending Jan 31, 2028, the consensus EPS estimate is $16.11, with estimates from $12.66 to $19.07 from 5 analysts.
What revenue do analysts expect from Argan next year?
For the fiscal year ending Jan 31, 2027, the consensus revenue estimate is $1.40B, with estimates from $1.35B to $1.47B. For the fiscal year ending Jan 31, 2028, the consensus revenue estimate is $1.69B, with estimates from $1.50B to $1.85B.
How many analysts cover AGX?
5 analysts rate Argan stock, and 5 analysts estimate its EPS for the fiscal year ending Jan 31, 2027.
AGX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts